<DOC>
	<DOCNO>NCT01042106</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics multiple ascend dos DSP-8658 patient Type 2 diabetes mellitus healthy adult .</brief_summary>
	<brief_title>Safety , Pharmacokinetics Pharmacodynamics DSP-8658 Patients With Type 2 Diabetes Mellitus Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diabetic subject Age ≥ 18 ≤ 65 year Body Mass Index ≤45 Drug naive type 2 diabetes type 2 diabetes previously treat oral antidiabetic drug Healthy subject Age ≥ 18 ≤ 65 year Body Mass Index ≥ 18 ≤ 29 Good health determine medical history , ECG , clinical chemistry , hematology , urinalysis , virology , physical examination . Diabetic subject Have current expect requirement antidiabetic lipidlowering drug Healthy subject Have , history clinically significant neurological , urological , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematological , major disorder include cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>diabetes</keyword>
</DOC>